Eprosartan in secondary prevention of stroke: the economic evidence.
Wessels
Francois
F
Outcomes Consultants, Pretoria, South Africa.
D000179:Acrylates / Q000191:economics / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D006801:Humans; D007093:Imidazoles / Q000191:economics / Q000627:therapeutic use; D017059:Models, Econometric; D020913:Perindopril / Q000191:economics / Q000627:therapeutic use; D013019:South Africa; D020521:Stroke / Q000517:prevention & control*; D013876:Thiophenes / Q000191:economics / Q000627:therapeutic use
D000179:Acrylates; D000959:Antihypertensive Agents; D007093:Imidazoles; D013876:Thiophenes; C068373:eprosartan; D020913:Perindopril